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Obesity and associated metabolic disorders like insulin 
resistance (IR), type 2 diabetes (T2D) and non-alcoholic 
fatty liver disease (NAFLD) are  marked  by  a  state  of  
 
 
















































inflammation initiated by nutrient overload [1]. 
Metabolic inflammation in obesity, in contrast to the 
classical immune response to injury or infection, is 
modest and without apparent resolution over time [1]. 
Although it is well established that metabolic 






























development of metabolic  inflammation and  insulin resistance (IR)  in diet‐induced obesity. To confirm our hypothesis that
adipose tissue (AT) inflammation is initiated prior to hepatic inflammation, C57BL/6J male mice were fed a low‐fat diet (LFD;





genes  Tnf,  Il1β,  Mcp1  and  F4/80.  As  hepatic  inflammation  was  not  detected  until  40  weeks  of  HFD,  we  show  that  AT
inflammation  is established prior  to  the development of hepatic  inflammation. Thus, AT  inflammation  is  likely  to have  a
greater contribution to the development of IR compared to hepatic inflammation. 
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inflammation disrupts cellular metabolism and impairs 
insulin signalling in metabolically active tissues, the 
underlying mechanisms are as yet ill-defined [2]. 
 
Adipose tissue (AT) is an important site of 
inflammatory events in obesity. It contains various cell 
types that all contribute to the inflammatory response 
during obesity. In addition to regulating fat mass and 
nutrient homeostasis, adipocytes mediate the 
inflammatory response through the secretion of 
adipokines, cytokines, and chemokines that enhance the 
recruitment of immune cells, especially macrophages, to 
the AT [3]. These AT macrophages (ATMs) are a major 
source of pro-inflammatory cytokines and chemokines 
and once activated can propagate the inflammatory state 
and interfere with insulin sensitivity in insulin target 
cells [4]. Although, prolonged nutrient overload results 
in metabolic inflammation associated with adipocyte 
expansion and dysfunction, metabolic inflammation in 
obesity is not restricted to the AT; the liver is also a 
strong contributor to the development of this type of 
inflammation [5–7]. Indeed, the production of pro-
inflammatory cytokines secreted by resident 
macrophages in the liver is linked to disruption of 
hepatic insulin signalling [8]. Consistent with this, 
enhanced expression of inflammatory genes in the liver 
following high-fat diet (HFD) feeding is associated with 
reduced insulin sensitivity in mice [9,10]. Thus, 
metabolic inflammation in both organs is associated 
with the development of IR. However, what tissue 
provides the main contribution to the development of IR 
remains unknown. 
 
Few studies have addressed the temporal relationship 
between AT and liver inflammation in the etiology of 
IR. Nevertheless, it is generally accepted that AT is an 
important initiator of the inflammatory response to 
obesity [4,11], engaging in crosstalk with the liver to 
affect liver metabolism and IR [12,13]. On the contrary, 
others have shown that this crosstalk in the development 
of HFD-induced metabolic derangements is 
bidirectional [14,15]. Furthermore, hepato-specific 
targeting of endoplasmatic reticulum stress was 
associated with decreased obesity and AT inflammation 
in ob/ob mice [14], underscoring the existence of 
crosstalk between the liver and the AT in obesity. The 
sequence of inflammatory processes in adipose and 
hepatic tissues in respect to the development of IR thus 
represents a topic of debate. 
 
This study aims to elucidate the initiation and sequence 
of inflammatory events in the adipose and hepatic 
tissues in obesity, and to determine the contribution of 
these individual inflammatory processes to the overall 
development of metabolic inflammation and IR. We 
hypothesize that liver inflammation comes secondary to 
adipose tissue inflammation and is of lesser importance 





Body weight gain stabilizes after prolonged HFD-
feeding in mice 
 
Body weight and AT mass were measured in mice fed a 
LFD and HFD for 24, 40 and 52 weeks, at the age of 36, 
52 and 64 weeks respectively (Fig. 1A) to assess the 
development of obesity over time. As expected, we 
observed a rapid increase in body weight in mice fed a 
HFD, which was significant from 12 weeks following a 
diet onwards (Fig. 1B). Body weight gradually 
increased between mice fed a HFD for 24 weeks and 40 
weeks (Fig. 1B; p<0.001) and remained at the same 
level in mice fed a HFD for 52 weeks compared to HFD 
for 40 weeks (Fig. 1B). In addition, weights of the 
mesenteric, gonadal/epidydimal and perirenal fat depots 
were significantly increased in mice fed a HFD for 24, 
40 and 52 weeks as compared to their age-matched LFD 
controls (Fig. 1C-E). We observed no difference in all 
three fat depots between mice fed a HFD for 24, 40 or 52 
weeks (Fig. 1C-E), suggesting a steady degree of 
adiposity following its initial establishment. Liver weight 
was significantly higher in mice fed a HFD for 24, 40 and 
52 weeks as compared to LFD controls (Fig. 1F).  
 
Improved insulin sensitivity upon prolongation of 
HFD-feeding in mice  
 
Since obesity is associated with IR, we next monitored 
insulin sensitivity in mice fed a HFD for 24, 40, and 52 
weeks. In mice fed a HFD at all points in time the fasted 
glucose levels were not affected (Fig. 2A), but fasted 
insulin levels in mice fed a HFD for 24 and 40 weeks 
were significantly elevated (Fig. 2B), suggesting a 
reduction in insulin sensitivity in these mice. 
Furthermore, we performed an oral glucose tolerance 
test (OGTT) and measured glucose and insulin levels 
simultaneously during the OGTT. At 24 weeks of HFD 
feeding, glucose tolerance was negatively affected, as 
evidenced by elevated glucose levels during the OGTT 
(Fig. 2D; p<0.01 at t=90 and p<0.05 at t=120, Suppl. 
1A; p<0.05) when compared to age-matched LFD 
controls. Furthermore, insulin levels were significantly 
increased in 24-week HFD fed mice compared to age-
matched LFD controls (Fig. 2D, Suppl. 1B), confirming 
the existence of IR at this point in time. Whole-body 
glucose tolerance was also significantly impaired in 
mice fed a HFD for 40 weeks, as mice displayed 
elevated   insulin   levels   during   the   OGTT  (Fig.  2E,  
  




































Suppl. 1B), whereas blood glucose levels remained 
stable (Fig. 2E, Suppl. 1A).  In contrast, we observed no 
signs of apparent glucose intolerance in mice fed a HFD 
for 52 weeks, as glucose levels did not differ (Fig. 2F, 
Suppl. 1A) and plasma insulin was significantly 
increased only after 15 min following gavage (Fig. 2F, 
Suppl. 1B). In support of the glucose tolerance data, 
homeostasis model assessment of IR (HOMA-IR) 
showed values to be significantly higher in the 24- and 
40-week HFD-fed mice as compared to their age-
matched LFD controls (Fig. 2C); this suggests a state of 
IR in mice fed a HFD for 24 and 40 weeks. HOMA-IR 
was not increased in mice fed a HFD for 52 weeks, 
confirming the absence of IR in these mice (Fig. 2C).  
 
Inflammation in AT is apparent at 24 weeks of HFD 
feeding 
 
Hematoxylin and Eosin (H&E) staining of gonadal 




































adipocyte size in mice fed the HFD. The number of 
cells per mm2 was significantly reduced by 24, 40, and 
52 weeks of HFD-feeding, confirming an increased 
adipocyte size when compared to LFD age-matched 
controls (Fig. 3B). Furthermore, crown-like structures 
(CLS), representing an accumulation of macrophages 
around dead adipocytes, were apparent in AT samples 
of mice fed a HFD for 24, 40 and 52 weeks (Fig. 3A, 
insets). Scoring of CLS confirmed a significant 
difference to exist between LFD and HFD mice for 
every time point (Fig. 3C). To confirm the presence of 
AT inflammation, we next assessed the expression of 
various inflammatory genes. Indeed, the gene 
expression levels of the pro-inflammatory cytokine Tnf 
(Fig. 3D) and the genes encoding for proteins involved 
in macrophage infiltration, Mcp1 and F4/80 (Fig. 3E-
G), were significantly elevated in the adipose tissue of 
24-, 40- and 52-weeks HFD mice compared to LFD 
mice. Il1ß was only significantly elevated in HFD mice 




and  52  weeks.  Values  shown  are  means  ±  SEM  (n  =  10‐15  mice/group).  Significance  level  set  at  p<0.05. 
*=significant from LFD at same time point, †=significant from same diet 24w, ‡=significant from same diet 40w. 
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inflammatory genes, the anti-inflammatory gene Il-10 
was significantly elevated in the AT of HFD mice at 24 
and 40 weeks (Fig. 3H). Furthermore, we observed a 
decrease in Tnf and F4/80 expression in 52-weeks HFD 
fed mice compared to mice fed a HFD for 40 weeks 
(Fig. 3D, Tnf; p<0.05 and Fig. 3G, F4/80; p<0.05), 
whereas Il-10 expression increased over time in LFD 
mice (Fig. 3H, 52-weeks LFD vs 24-weeks LFD: 
p<0.001; 52-weeks LFD vs 40-weeks LFD: p<0.05). 
 
Hepatic inflammation gradually develops over time 
in mice fed a HFD  
 
H&E staining of liver slides (Fig. 4A) indicated the 
presence of HFD-induced hepatic steatosis from 24 
weeks onwards, which was confirmed by a significant 
elevation in the amount of neutral lipids in the liver 
(TG; Fig. 4B). Histopathological examination of liver 
sections showed an increase in steatosis grade at 52 
weeks as compared to 24 weeks of HFD-feeding (Fig. 
4C; p<0.05), suggesting a progression in the 
accumulation of hepatic lipids over time. Although 
prolonged HFD-feeding significantly increased the 
percentage of microvesicular steatosis over macro-






























Furthermore, we observed a significant increase in the 
NAFLD activity score (NAS) (Fig. 4E), the number of 
inflammatory foci (Fig. 4F) and hepatocellular 
ballooning (Fig. 4G) for all HFD groups as compared to 
LFD groups. In line with a progression in steatosis 
grade, we also observed an increase in both the NAS 
score (Fig. 4E; p<0.05) and the number of inflammatory 
foci (Fig. 4F; p<0.001) in mice fed a HFD for 40 weeks 
as compared to the 24-weeks HFD group. To further 
investigate inflammation we measured the expression of 
pro- and anti-inflammatory cytokines (Tnf, Il1ß, Il-10) 
and macrophage markers (Mcp1, F4/80) in the liver. 
Tnf, Il1ß, Il-10, Mcp1, and F4/80 expression was 
significantly upregulated at 40 weeks of HFD-feeding 
but not 24 weeks of HFD-feeding compared to mice fed 
the LFD. Furthermore, no difference was observed in 
expression level of Tnf, Mcp1 and Il-10 at 52 weeks of 
HFD-feeding, whereas Il1ß and F4/80 were still 
significantly elevated at this time point (Fig. 4H-L). In 
addition, Mcp1 expression was significantly reduced in 
HFD52 mice compared to HFD40 mice (Fig 4I). We 
also observed an age-related decline in F4/80 
expression as represented by a significant reduction in 

























































































Plasma adipokine and cytokine levels during 
prolonged HFD-feeding in mice  
 
Both leptin and adiponectin are associated with obesity, 



















































HFD-feeding mediates the secretion of leptin and 
adiponectin, we measured the plasma levels of these 
adipokines throughout the dietary period. As expected, 
leptin was significantly increased in mice fed a HFD 
compared to LFD, reaching a maximum around 24 weeks 
Figure 3. Prolonged HFD‐feeding  leads  to AT  inflammation  in mice  after  24 weeks.  (A)  Representative 
pictures from H&E‐stained AT sections of LFD and HFD mice after 24 (left), 40 (middle) and 52 (right) weeks of diet 
with crown‐like structures  (insets). Histologically quantified number of  (B) adipocytes and  (C) crown‐like structures 
per mm2  (n=10‐15).  (D‐H) mRNA  expression  levels  of  tumor  necrosis  factor  (Tnf),  interleukin‐1β  (Il1β), monocyte 
chemotactic protein‐1 (Mcp1), macrophage marker (F4/80) and interleukin‐10 (Il‐10) in the AT. All mRNA expression 
data were normalized  to  the  LFD24 group and expressed as mean ± SEM  (n=7‐8). Significance  level  set at p<0.05. 
*=significant from LFD at same time point, †=significant from same diet 24w, ‡=significant from same diet 40w. 
  
















































































































and  52  (right) weeks  of  diet with  inflammatory  foci  (arrows;  insets).  (B) Quantification  of  hepatic  triglycerides.  (C) 
Determination  of  steatosis  grade  (0=0‐5%;  1=5‐33%;  2=33‐66%;  3=66‐100%  coverage),  and  (D)  percentage  of 
microvesicular over macrovesicular steatosis. (E) Determination of NAFLD Activity Score (NAS; sum of steatosis + lobular 
inflammation  + ballooning),  score  >5  represents  steatohepatitis  (SH)  and pathological  scores  <3 non‐steatohepatitis 
(NSH). (F) Quantification of  inflammatory foci per 5 random fields under 200x magnification and (G) determination of 
ballooning score. (H‐L) mRNA expression levels of tumor necrosis factor (Tnf), monocyte chemotactic protein‐1 (Mcp1), 
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(Fig. 5A). Plasma leptin concentrations exhibited very 
strong correlation with body weight (Fig. 5B). Serial 
adiponectin levels did not change in time or as a result 
of HFD-feeding (Fig. 5C). After 24 weeks of HFD, the 
circulating pro-inflammatory mediators, TNF, IL-6, and 
mKC, as well as the anti-inflammatory mediator IL-10 
were up-regulated (Fig. 5D), confirming immunological 




To date, the detrimental role of metabolic inflammation 
in the etiology of IR has become irrefutable [10]. Despite 
the fact that inflammation in AT and liver are both 
associated with IR, their individual contribution to the 
development of metabolic inflammation remains elusive. 
Here, we have explored the temporal relationship 
between AT and liver inflammation in the development 
of metabolic inflammation. We show that chronic 
metabolic inflammation is apparent in the visceral AT 
depot at 24 weeks of HFD-feeding (Fig. 3), whilst overt 
hepatic inflammation does not occur until 40 weeks of 
HFD-feeding (Fig. 4). This implies that AT inflammation 
precedes hepatic inflammation in mice fed an obesogenic 
diet. Furthermore, as IR was established before the 
development of clear hepatic inflammation and did not 
further progress, our data also suggest that obesity-




























inflammation rather than hepatic inflammation. 
 
In agreement with previous reports demonstrating that 
HFD-feeding favours the development of obesity [10,16], 
our data show that body weight gain increased rapidly 
within the initial 12-24 weeks of HFD-feeding (Fig. 1B). 
Prolonged HFD-feeding in mice led to a further, yet 
marginal, increase in body weight up to a maximum at 
about 40 weeks of HFD-feeding. Weight gain then 
levelled off and weight remained high until the end of the 
study. Although we used male mice in our study, 
previous studies observed a similar growth pattern in 
female mice fed a HFD-diet (60% kcal fat) for up to 12 
months [16]. In the female mice the increase in body 
weight was greater during the first 12 weeks and slower 
during subsequent weeks of HFD-feeding. Correspond-
ing to the rate of body weight gain in mice fed a HFD, 
plasma leptin levels were significantly increased compar-
ed with mice fed a LFD (Fig. 5). Indeed, as adipocytes 
expand due to enhanced triglyce-ride storage, leptin 
secretion increases proportionately [17]. However, leptin 
levels significantly declined with prolonged HFD-feeding 
(±30 weeks of HFD-feeding) although body weight 
remained high (Fig. 5A, B). Leptin levels also declined in 
mice fed the LFD, suggesting an age-related decline in 
circulating leptin. This has previously been observed in 
rodents [18] and also in the human population leptin 




























prolonged HFD  in mice. (A) Serial plasma  leptin and (B)  its 
correlation  with  body  weight,  and  (C)  serial  plasma 
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Although AT is an important initiator of the 
inflammatory response to obesity [4], few studies have 
addressed the temporal relationship between AT and the 
liver in the development of metabolic inflammation. 
Here we show that 24 weeks of diet-induced obesity 
indeed led to an increase in AT inflammation. In 
contrast to Tnf, Mcp1 and F4/80, Il1β was not elevated 
at the 24-week time point (Fig. 3D). However, we 
cannot fully exclude that Il1β was not expressed at this 
time point, since cytokine expression was not measured 
in the stromal vascular fraction but in AT lysates only, 
which may have led to an underrepresentation of the 
results. Of note, gene expression of the anti-
inflammatory cytokine Il-10 was persistently elevated in 
HFD mice as well. This is in agreement with previous 
studies in mice [20] and humans [21] and likely 
represents a protective response of the body to 
counteract pro-inflammatory events.  
 
Other longitudinal studies investigating the 
development of adipose and liver inflammation found 
that both organs exhibit a very similar response to HFD 
feeding at the level of transcriptional master regulators 
[22]. However, the response at the level of genes 
controlled by these regulators was tissue-specific and, 
importantly, the authors observed a delayed response in 
the liver when compared to the AT, which is consistent 
with our findings.  What causes this delayed 
inflammatory response remains to be elucidated. 
However, it has been shown that systemically 
administered cytokines can exert pro-inflammatory 
effects on the liver. Especially TNF and leptin are 
known to play a role in the pathogenesis of NAFLD 
[23,24]. Here, we show that AT inflammation is 
associated with the enhanced secretion of TNF and 
leptin to the circulation after 24w of HFD (Fig. 5). 
Since the visceral AT depot directly drains into the 
portal circulation, this may support the notion of 
crosstalk between dysfunctional AT and the liver. Thus, 
our results indicate that metabolic inflammation in 
obesity is initiated in the AT and in time progresses to 
the liver. Therefore, our data suggest that the liver does 
not play a role in the initial development of metabolic 
inflammation in mice but may serve as a contributor to 
metabolic inflammation following its establishment. 
  
Aging is associated with increased visceral adiposity 
[25,26], AT inflammation and a systemic increase in 
pro-inflammatory cytokines [27], thus closely 
resembling the pathophysiology in obesity. Given that 
this inflamm-aging is linked with various age-associated 
disorders [28], targeting inflammatory pathways could 
prevent or alleviate the pathological consequences 
observed in the course of aging, obesity or both in 
parallel. Over the last decade mTOR inhibitors, 
especially rapamycin, have shown promising effects on 
extending life- and health span in animal models of 
aging [29,30] and obesity [31], effects that, at least for 
obesity, may be attributed to rapamycin’s anti-
inflammatory properties in the AT [32]. Whether this 
may be applied to the human setting to increase health 
span in the growing aging population remains unknown. 
 
Our data also show that IR was induced in mice fed a 
HFD for 24 weeks compared with LFD mice. Since at 
this point AT inflammation was present, in the absence 
of clear hepatic inflammation, this may suggest AT 
inflammation is more likely to contribute to obesity-
associated IR. This observation accords with our 
previous reports regarding the dissociation of hepatic 
inflammation and IR and suggests a greater contribution 
of adipose inflammation to development of IR than 
hepatic inflammation [33,34]. Our study design, 
however, does not allow for assessing whether AT 
inflammation triggers systemic IR or vice versa since at 
our earliest time point (24 weeks HFD-feeding) both IR 
and AT inflammation were observed. It has, however, 
been shown previously that AT inflammation is 
necessary for long-term but not short-term HFD-
induced IR, which is more likely related to acute tissue 
lipid overload [10]. 
 
Nevertheless, our data also show that prolonged HFD 
feeding is associated with improved insulin sensitivity 
over time, as we did not observe signs of glucose 
intolerance in mice fed a HFD for 52 weeks (Fig. 2, 
Suppl. 1). This increase in insulin sensitivity was 
already observed in mice fed a HFD for 40 weeks 
compared to 24 weeks. Although the observed 
alleviation of IR clearly warrants further study it is 
known that insulin responses and insulin levels decline 
with age in the human population [35]. This could 
reflect beta cell failure in aging, or might be due to 
alterations in gastric emptying, delayed nutrient 
absorption, or enhanced insulin sensitivity in older age 
[36]. Furthermore, an age-related decline in renal 
function may also affect glucose metabolism and impair 
insulin secretion [36,37]. Whether any of these factors 
can explain the amelioration of insulin sensitivity in our 
study remains to be investigated. In addition, the high 
serum leptin levels as observed in mice fed the HFD 
may have resulted in inhibition of insulin release from 
the pancreas [38]. Furthermore, the apparent 
improvement in insulin sensitivity in our study may also 
be related to the attenuated inflammatory phenotype of 
the AT observed with aging. Indeed, AT of mice fed a 
52-week diet of HFD had a reduced expression of the 
inflammatory genes Tnf and F4/80 in comparison with 
mice fed a HFD for 40 weeks. Although this could 
reflect the reciprocal relationship between inflammation 
  
www.impactaging.com                      8                                         AGING, April 2015, Vol. 7 No.4 
and IR, it should be noted that the reduced expression of 
inflammatory genes was not paralleled by a reduced 
number of crown-like structures in the AT (Fig 3C). A 
similar trend was observed for the liver, in which Mcp1 
expression was significantly reduced in mice fed a HFD 
for 52 weeks compared with mice at 40 weeks. This 
may seem paradoxical at first sight, however, this 
finding may be explained at the macrophage’s 
functional level where it has been reported that with 
aging macrophages obtain a reduced capacity to become 
activated into a pro-inflammatory state by chemokines 
and cytokines [39], thus allowing a similar amount of 
macrophages to be associated with a reduced cytokine 
expression with age. Nevertheless, the influx of 
macrophages to the AT is less impressive with aging 
and it has been suggested that (pre-) adipocytes, rather 
than macrophages, are the major source of inflammation 
in aging [40]. Although we cannot discriminate between 
the different cell types involved in AT and liver 
inflammation, aging by itself did not result in 
upregulation of pro-inflammatory genes and cytokines 
in LFD52 mice. This is in discrepancy with the study by 
Wu et al. and may be explained by the longer duration 
(22-24 months) and different strain of mice 
(C57BL/6JNIA) used in their study. Nevertheless, Il-10 
was significantly increased in time suggesting some 
degree of age-induced immunological activation in our 
study.  
 
Taken together, we provide evidence that obesity-
induced metabolic inflammation in the AT precedes 
inflammation in the liver, suggesting that the liver does 
not play a role in the initial development of metabolic 
inflammation. Furthermore, we show that hepatic 
inflammation is of lesser importance to the development 
of insulin resistance compared to AT inflammation. 
Therefore, targeting AT inflammation may help to 
control metabolic inflammation in obesity and aging in 
mice by both delaying its initiation and subsequent 
progression to other organs such as the liver. Further 
research is warranted for successful extrapolation of the 
research results to human clinical conditions. 
 
MATERIALS AND METHODS 
 
Animals and diet intervention. All procedures were 
performed with approval of the University of Groningen 
Ethics Committee for Animal Experiments (experiment 
registered as 6141B), which adheres to the principles 
and guidelines established by the European Convention 
for the Protection of Laboratory Animals. Experiments 
were carried out on male C57BL/6j mice (Charles 
River, JAX laboratories, France), individually housed in 
a temperature-controlled room under a 12 h light-dark 
cycle with ad libitum access to water and food, unless 
stated otherwise. After arrival at our laboratories the 6-
week old C57BL/6j male mice received a low-fat diet 
(LFD) containing 10% fat from lard (D12450HY, 
Research Diets Inc., NJ, USA) for 6 weeks until the 
start of the experiment, at which time the animals were 
12 weeks old. After this run-in period, randomly 
divided groups of animals were either kept on the LFD 
or switched to a high-fat diet (HFD) containing 45% fat 
from lard (D12451, Research Diets Inc.). Experiments 
were performed on mice after 24, 40 and 52 weeks of 
HFD-feeding unless stated otherwise. To ensure that 
observations took place in a state of chronic obesity, 
animals exhibiting a weight loss >15% at sacrifice, 
compared with their peak body weight were excluded 
from the analyses. Six mice were excluded from the 
study due to the development of dermatitis, that is n=2 
in the HFD24 group, n=3 in the HFD52 group, and n=1 
in the LFD52 cohort. Final group sizes were n=13 for 
LFD24, n=13 for HFD24, n=15 for LFD40, n=15 for 
HFD40, n=13 for LFD52 and n=10 for HFD52. 
 
Oral glucose tolerance test. Three weeks prior to 
sacrifice subsets of mice (n=7 per group) were fasted 
for 6 hours and received a glucose bolus (2 g/kg; 40% 
glucose solution (w/v) by oral gavage. Average gavage 
volume was 180±13 and 250±24 μl for LFD- and HFD-
mice, respectively. Glucose levels were measured with 
the OneTouch Ultra glucometer (Lifescan Benelux, 
Beerse, Belgium) before and 15, 30, 45, 60, 90, and 120 
minutes after the gavage by puncturing the saphenous 
vein of the left hind limb. Blood samples collected prior 
to glucose administration and at 15, 30, 60 and 120 
minutes were used to simultaneously assess plasma 
insulin levels. HOMA-index for systemic IR was 
calculated as described elsewhere [41]. 
 
Analysis of plasma parameters. Plasma insulin was 
determined by ELISA (Alpco ultrasensitive, Alpco, 
Tilburg, The Netherlands). Plasma leptin and 
adiponectin were determined by ELISA (R&D systems, 
Abingdon, UK). Plasma levels of interleukin IL-1β, IL-
2, IL-5, IL-6, IL-10, IL-12  and mKC (CXCL-1), p70, 
TNF and IFN-γ were measured using Meso Scale 
Discovery (Gaithersburg, USA) 10-plex multispot 
Mouse cytokine assay for plasma, according to the 
manufacturer’s instructions. Intra- and inter-assay 
coefficients of variation were, respectively, IL-10 (15.8 
and 31.2%), IL-6 (11,5 and 3.3%), mKC (8.3 and 
13.7%) and TNF (6.4 and 16.3%). Concentrations of 
IFN-γ, IL-12, p70, IL-1β, IL-2, IL-5 were below the 
detection limit of the assay.  
 
Liver and AT Histology. Three different visceral 
adipose depots (i.e. surrounding the intestine; 
mesenteric, the kidney; perirenal, and the gonads; 
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gonadal/epidydymal) were isolated and weighed at 
sacrifice. Subsections were partially embedded in 
paraffin and snap frozen and stored at -80˚C for further 
analyses. The frozen gonadal fat depot was crushed in 
liquid nitrogen for RNA isolation. Livers were 
collected, trimmed, and trimmed sections were fixed in 
10% paraformaldehyde. Paraffin-embedded liver and 
AT  sections (4 μm)  were stained  with Hematoxylin/ 
Eosin (H&E) for morphological examination. Scoring 
of hepatic steatosis and steatohepatitis (NAFLD activity 
score NAS) was performed in an unbiased manner by 
two board-certified veterinary pathologists (SAY, AdB) 
using a method described previously [42]. 
 
To estimate adipocyte size, the number of adipocytes 
per mm2 was determined on scanned sections by 
manually counting all the adipocytes in an area of 4-5 
mm2, using Aperio ImageScope (Leica Biosystems 
Imaging Inc., CA, USA). Slides were scanned with the 
NanoZoomer 2.0-HT slide scanner from Hamamatsu 
(Herrsching am Ammersee, Germany).  
 
Liver lipids. Total liver lipids were extracted from the 
liver according to the Bligh and Dyer method [43], as 
previously explained [44], and measured biochemically. 
Hepatic triglycerides (TG) were quantified using 
commercially available kits  (Hitachi, Roche, Woerden, 
The Netherlands).  
 
Quantitative Real-Time PCR (qRT-PCR). Total RNA 
was isolated from the liver and AT using RNeasy Mini 
plus and RNeasy Lipid Tissue Mini kits (Qiagen, 
Wetburg, Leusden, The Netherlands), respectively, 
according to the manufacturer’s instructions. RNA 
integrity was determined by agarose gel electrophoresis.  
RNA quantity (OD-260) and quality (260/OD-280) 
were determined using an ND-1,000 spectrophotometer 
(NanoDrop Technologies, Rockland, DE). Total RNA 
(1 μg) was converted into cDNA using a Quantitect 
Reverse Transcription kit (Roche, Mannheim, 
Germany) according to the manufacturer’s instructions. 
Real time PCR (RT-PCR) was performed using a 
7900HT system (Applied Biosystems, Warrington, UK) 
as previously explained [45] by using Power SYBR 
Green Master Mix (Roche, Mannheim, Germany). 
Values were corrected using the housekeeping gene 
Cyclophillin A (Ppia). Primer sequences are available 
in Supplementary Table 1.  
 
Statistical analysis. Data are expressed as means ± 
standard error of the mean (SEM). Data were 
statistically analysed using GraphPad Prism (version 
5.00 for Windows, GraphPad Software, San Diego, CA, 
USA). Non-parametric Mann-Whitney U tests were 
performed for comparing LFD and HFD groups within 
a time point, and Kruskall Wallis ANOVA with Dunn’s 
post hoc test was used to determine differences between 
time points within the designated diet. Statistical 
analyses with p-value smaller than 0.05 were considered 
significant.                                                      
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Gene  Forward primer 5’-3’ Reverse primer 5’-3’ 
F4/80 TGTGTCGTGCTGTTCAGAACC AGGAATCCCGCAATGATGG 
Mcp1 GCTGGAGAGCTACAAGAGGATCA  ACAGACCTCTCTCTTGAGCTTGGT  
Il1β TGCAGCTGGAGAGTGTGG TGCTTGTGAGGTGCTGATG 
Il10 GCTCTTACTGACTGGCATGAG CGCAGCTCTAGGAGCATGTG 
Tnf GTAGCCCACGTCGTAGCAAAC AGTTGGTTGTCTTTGAGATCCATG 
Ppia TTCCTCCTTTCACAGAATTATTCCA CCGCCAGTGCCATTATGG 
   
Supplementary  Figure  1.  Glucose  and  insulin  during 
OGTT.  (A)  Glucose  and  (B)  insulin  homeostasis  during  oral 
glucose  tolerance  test  (OGTT)  quantified  by  area  under  curve 
(AUC) based on data in Fig. 2B‐E. Significance level set at p<0.05. 
*=significant  from  LFD  at  same  time  point,  †=significant  from 
same diet 24w, ‡=significant from same diet 40w. 
